Teplizumab in stage 2 type 1 diabetes: clinical practice experience on feasibility in 3 adult patients
Guarnotta V, Pantò F, Vigneri E, et al.
Diabetes Obes Metab. Pub. online 8 Mar 2026.
Leggi
Guarnotta V, Pantò F, Vigneri E, et al.
Diabetes Obes Metab. Pub. online 8 Mar 2026.
Leggi
Poljo A, Reichl JJ, Kollmann L, et al.
Diabetes Obes Metab. Pub. online 8 Mar 2026.
Leggi
Magliano DJ, Morton JI, Chen L, et al.
Lancet Diabetes Endocrinol. Pub. online 9 Mar 2026.
Leggi
Blumenthal RS, Morris PB, Gaudino MF, et al.
JACC. Pub. online 13 Mar 2026.
Leggi
Vessari H, Prami T, Peltonen EJ, et al.
Diabetes Obes Metab. Pub. online 9 Mar 2026.
Leggi
Bruttomesso D, Petrie JR, Evans M, et al.
Diabetes Care. Pub. online 12 Mar 2026.
Leggi
Umpierrez GE, Shah VN, Brady V, et al.
J Diabetes Sci Technol. Pub. online 7 Mar 2026.
Leggi
Hussain S, Tree T, Mathieu C, et al.
Diabetes Obes Metab. Pub. online 12 Mar 2026.
Leggi
Gentile S, Fiorentino R, Lettieri M, Guarino G, Marino G, Tommasi E, Frison V, Satta E, Chiarello M, Caccavale G, Masuccio E, Strollo F; on behalf of AMD-OSDI Study Group on Insulin Therapy
Diabetology. Pub. online 9 Mar 2026.
Leggi
De Cosmo S, Russo G, Nicolucci A, et al.
Clin Kidney J. Pub. online 2 Mar 2026.
Leggi